Skip to content
Disclosery

TAKEDA PHARMACEUTICAL CO LTD: OVID position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of TAKEDA PHARMACEUTICAL CO LTD on OVID, newest first. How the timeline and the estimate are built.

TAKEDA PHARMACEUTICAL CO LTD held 7,531,996 OVID shares at 2025-09-30 per its 13F-HR filed 2025-11-13.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 7,531,996 shares
    Change vs previous 13F 0 shares

    59.82% of the 13F portfolio, value $9,791,595.

    13F-HR 0001395064-25-000157 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-06-30
    13F 7,531,996 shares
    Change vs previous 13F 0 shares

    12.71% of the 13F portfolio, value $2,485,380.

    13F-HR 0001395064-25-000124 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 7,531,996 shares
    Change vs previous 13F 0 shares

    14.51% of the 13F portfolio, value $2,349,805.

    13F-HR 0001395064-25-000055 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 7,531,996 shares
    Change vs previous 13F 0 shares

    26.4% of the 13F portfolio, value $7,011,884.

    13F-HR 0001395064-25-000019 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 7,531,996 shares
    Change vs previous 13F 0 shares

    23.42% of the 13F portfolio, value $8,887,755.

    13F-HR 0001395064-25-000030 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2024-06-30
    13F 7,531,996 shares
    Change vs previous 13F 0 shares

    2.49% of the 13F portfolio, value $5,792,461.

    13F-HR 0001395064-25-000028 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-03-31
    13F 7,531,996 shares
    Change vs previous 13F 0 shares

    7.95% of the 13F portfolio, value $22,972,588.

    13F-HR 0001395064-25-000026 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2023-12-31
    13F 7,531,996 shares
    Change vs previous 13F not available

    7.41% of the 13F portfolio, value $24,253,027.

    13F-HR 0001395064-25-000024 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).